Cannara Biotech Inc.
Research Cannara Biotech Inc. (8CB0) on Bullrun: market cap EUR 125.45M, P/E 18.1. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker8CB0
- ExchangeF
- CountryCanada
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 125.45M
- P/E18.1
- Financial periodQ2 2026
- RevenueCAD 31.83M
- Net incomeCAD 4.84M
- Free cash flowCAD 1.28M
- Gross margin47.2%
Valuation Snapshot
latest market cap is EUR 125.45M; P/E is 18.1.
Peer valuation comparison
Latest P/E is 18.14x versus a Healthcare sector median of 24.46x (25.8% below).
Latest P/E is 18.14x versus a Canada median of 15.58x (16.4% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CAD 112.25M | CAD 11.81M | CAD 12.38M | 42.9% | n/a | CAD 16.52M | CAD 34.80M | CAD 111.21M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | EUR 125.45M | 18.1 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Cannara Biotech Inc.
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Cannara Biotech Inc.'s market cap?
Cannara Biotech Inc.'s market capitalization is EUR 125.45M.
What is Cannara Biotech Inc.'s P/E ratio?
Cannara Biotech Inc.'s price-to-earnings (P/E) ratio is 18.1.
What does Cannara Biotech Inc. do?
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.